Senate drops stem cell provision; OA likely to pass

Written byAndrea Gawrylewski

| 2 min read

The US Senate dropped language from a bill yesterday that would have directed federal money to research on stem cell lines derived before June 15, 2007, the linkurl:Chronicle of Higher Education;http://chronicle.com/news/article/3262/senate-removes-stem-cell-provision-opposed-by-bush-from-spending-bill reported. The move was made in hopes to avert a presidential veto over the stem cell provision. The language was part of a Senate Appropriations Committee budget measure for 2008, proposed in June of this year, which would allow research on 400 lines of stem cells derived in private academic and independent laboratories. The $152 billion spending bill also includes provisions for the Departments of Education and Health and Human Services. Word is that the president -- as he has in the linkurl:past;http://www.the-scientist.com/blog/display/53063/ -- may still veto the bill, despite the removal of the stem cell language, because of the high level of spending. "We wanted to show that we are willing to compromise," said Sen. Tom Harkin, democrat from Iowa, in a floor statement. "We're willing to try to meet the president halfway." In response to strident federal restrictions on stem cell research, many linkurl:states;http://www.the-scientist.com/blog/display/53690/ have engineered funding plans of their own; New Jersey voters will vote whether to borrow $450 million for stem cell research on November 6. The bill, if passed, would also require all research funded by the National Institutes of Health to be open access, as we reported in linkurl:July;http://www.the-scientist.com/news/display/53366/,%22 . "The strengthened NIH open access policy in the Appropriations Bill provides a valuable opportunity to enhance access to the results of biomedical research funded by US taxpayers," Matt Cockerill, the publisher of BioMed Central (a sister company of The Scientist) wrote to me in an Email this morning. Funders around the world have recognized the benefits of open access, he added, and "an open access mandate from NIH, the world's largest biomedical funder, is a natural next step."

Senate drops stem cell provision; OA likely to pass

The Scientist ARCHIVES

Become a Member of

Meet the Author

Andrea Gawrylewski

Related Research Resources

What Is the Amniotic Fluid Composed of?

Research Resources

Podcasts

Webinars

Videos

Infographics

eBooks

Skip the Wait for Protein Stability Data with Aunty

An Automated DNA-to-Data Framework for Production-Scale Sequencing

Exploring Cellular Organization with Spatial Proteomics

Organoid Origins and How to Grow Them

Products

Product News

BRANDTECH Scientific Introduces the Transferpette® pro Micropipette: A New Twist on Comfort and Control

Biotium Launches GlycoLiner™ Cell Surface Glycoprotein Labeling Kits for Rapid and Selective Cell Surface Imaging

Thermo Scientific X and S Series General Purpose Centrifuges

VANTAstar Flexible microplate reader with simplified workflows